Nvidia-backed biotech pairs a clinical-stage cancer pipeline with pharmaceutical partnerships as TRex Bio, Retension and Lycia join the IPO queue
October 8, 2026
Artificial intelligence has spent the past several years promising to transform drug discovery. Iambic Therapeutics is now asking Wall…